← All organizations

Esperion Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: Esperion Therapeutics | Esperion Therapeutics, Inc. | ESPERION THERAPS INC

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

First NDA

Last known activity

Aug 4, 2023

Timeline

2000s

Jun 1, 2008
Esperion Therapeutics— Founded

2020s

Feb 21, 2020
bempedoic acid— NDA Secondary Org
Feb 21, 2020
bempedoic acid— NDA Organization

Drugs by trial phase (7 distinct, 24 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 2 (5 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (2)

Recent trials (41)

NCT06021951Study directorPhase 4Aug 4, 2023
NCT06021951Lead sponsorPhase 4Aug 4, 2023
NCT05694260Lead sponsorPhase 2Jan 12, 2023
NCT05694260Study directorPhase 2Jan 12, 2023
NCT05263778CollaboratorPhase 4Mar 31, 2022
NCT03531905Lead sponsorPhase 2May 9, 2018
NCT03531905Study directorPhase 2May 9, 2018
NCT03337308Lead sponsorPhase 3Oct 23, 2017
NCT03337308Study directorPhase 3Oct 23, 2017
NCT03193047Lead sponsorPhase 2Apr 7, 2017
NCT03193047Study directorPhase 2Apr 7, 2017
NCT03067441Study directorPhase 3Feb 3, 2017
NCT03067441Lead sponsorPhase 3Feb 3, 2017
NCT03051100Lead sponsorPhase 2Jan 1, 2017
NCT03051100Study directorPhase 2Jan 1, 2017

Details

Founded: Ann Arbor, MI, US Jun 1, 2008
First NDA: Feb 21, 2020
Last known activity: Aug 4, 2023